Has Steven Kadiev, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,470 in general payments to Steven Kadiev, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Kadiev, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Kadiev, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Kadiev, MD

Pulmonary Disease · Charlotte, NCNPI 1962627414

Payments from drug & device makers

$2,470in general payments, 2019–2025

Across 32 payments — averaging $77.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Abiomed$133
Pulmonx Corporation$105
Advanced Respiratory, Inc$51
3b Medical, Inc.$13

What the payments were for

Travel & lodging$69428%
Food & beverage$1,77672%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	24	$2,168
Abiomed	4	$133
Pulmonx Corporation	1	$105
Advanced Respiratory, Inc	2	$51
3b Medical, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$1,655
Inspire Upper Airway Stimulation System$156
Pulmonx Endobronchial Valve EBV$105

How this compares

$2,470 in reported general payments places this provider in the 55th percentile of 393 pulmonary disease providers in North Carolina.

See all pulmonary disease providers in North Carolina →

Medicare billing

Part B allowed, 2024

$157,218

Medicare patients

507

Services billed

1,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OfevNintedanib Esylate	17	$246,084
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	155	$143,303
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	82	$47,158
Breo ElliptaFluticasone/Vilanterol	73	$46,677
Incruse ElliptaUmeclidinium Bromide	44	$23,123
Stiolto RespimatTiotropium Br/Olodaterol Hcl	23	$20,252
Spiriva RespimatTiotropium Bromide	13	$18,205
SymbicortBudesonide/Formoterol Fumarate	29	$10,004
Advair HfaFluticasone Propion/Salmeterol	14	$8,305
Albuterol Sulfate HfaAlbuterol Sulfate	231	$6,947
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	14	$5,042
Flovent HfaFluticasone Propionate	12	$3,348
Roflumilast	27	$2,965
Arnuity ElliptaFluticasone Furoate	12	$2,862
Montelukast Sodium	140	$2,157

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Charlotte

Selwyn SpangenthalCharlotte$7M
Walid EltaraboulsiCharlotte$247K
Jaspal SinghCharlotte$229K
Graham ScottCharlotte$228K
Thomas SternHuntersville$5.2M
Laurie SnyderDurham$3.8M
Scott PalmerDurham$3.8M
Michael PritchettPinehurst$2.2M
Anup BanerjeeGastonia$2.1M
Hubert FordChapel Hill$2M

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →